John R Fischer

Pacific Avenue snags KiddeFenwal in sale from Carrier Global Corporation

The U.S. Bankruptcy Court for the District of Delaware granted Pacific Avenue approval to acquire all assets of Kidde-Fenwal on April 2, 2024.

Exponential increase in healthcare data drives opportunities for PE

Competition for 'must-have' healthcare IT providers is intense, say Harris Williams' Sam Hendler and Dan Linsalata.

The healthcare valuation gap

High interest rates have made the cost of capital expensive and have led buyers to view certain assets as worth less than sellers’ asking prices, writes John R Fischer.

Acon's Anjali Jolly explains why PE likes specialty infusion care

Acon and Triton Pacific recently announced the sale of BioMatrix to Frazier Healthcare.

The impacts of AI on patient care are ‘once-in-a-generation,’ says Bain & Co’s Eric Berger

Successful investment deals around healthcare generative AI will be in products that are usable not just today but tomorrow as well.

Vet care sees strong PE demand: 4 deals announced in 2024, with more to come

L Catterton, Granite Creek, Mainsail Partners and Whistler Capital Partners are among the firms investing in veterinary care.

Shore Capital deployed its 'entire playbook' to grow Behavioral Innovations before sale

Shore founding partner John Hennegan discusses the sale of the autism therapy provider to Tenex.

Renovus Capital's new principal Gary Tang eyes opportunities in healthcare services

The former Chicago Pacific Founders vice president will help scale Renovus' healthcare services investment vertical.

AIC’s Drew Maloney urges PE firms to connect with lawmakers amid healthcare scrutiny

'It’s important that you define your own business before someone defines it for you,' Maloney said.

Lee Equity's John Eppler: PE investments in cardiology still in 'early innings'

In 2023, Lee Equity teamed up with Cardiovascular Institute of the South to form Cardiovascular Logistics.